glp-1 news today insurers coverage How many adults with private health insurance could use drugs How to Afford GLP-1s in

In a trial testing liraglutide in patients with type 2 diabetes, 28% more women than men reported adverse effects of the treatment

Chronic Pain Conditions Most Likely to Respond Not all chronic pain is the same, and the evidence varies by condition

The 2026 Math Flip: Brand name can be cheaper than compounded tirzepatide

Tirzepatide was shown to reduce oral contraceptive absorption by approximately 60%

Technical Architecture of ePA At the heart of ePA is the NCPDP SCRIPT standard, a set of transaction protocols originally developed for pharmacy claims

The mechanism has been suggested to involve inhibition of cardiac intracellular signaling pathways (Ca 2+ /calmodulin-dependent protein kinase II and protein kinase C) due to saxagliptin-mediated inhibition DPP-9 (136)